JP2023538522A5 - - Google Patents
Info
- Publication number
- JP2023538522A5 JP2023538522A5 JP2023507911A JP2023507911A JP2023538522A5 JP 2023538522 A5 JP2023538522 A5 JP 2023538522A5 JP 2023507911 A JP2023507911 A JP 2023507911A JP 2023507911 A JP2023507911 A JP 2023507911A JP 2023538522 A5 JP2023538522 A5 JP 2023538522A5
- Authority
- JP
- Japan
- Prior art keywords
- combination
- approximately
- drug according
- statin
- combination drug
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063062990P | 2020-08-07 | 2020-08-07 | |
| US63/062,990 | 2020-08-07 | ||
| US202163135946P | 2021-01-11 | 2021-01-11 | |
| US63/135,946 | 2021-01-11 | ||
| PCT/US2021/045008 WO2022032137A1 (en) | 2020-08-07 | 2021-08-06 | Methods for treating refractory hypercholesterolemia involving an angptl3 inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023538522A JP2023538522A (ja) | 2023-09-08 |
| JP2023538522A5 true JP2023538522A5 (enExample) | 2024-08-09 |
Family
ID=77543654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023507911A Abandoned JP2023538522A (ja) | 2020-08-07 | 2021-08-06 | Ａｎｇｐｔｌ３阻害剤を伴う難治性高コレステロール血症を処置するための方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US20220072127A1 (enExample) |
| EP (1) | EP4192446A1 (enExample) |
| JP (1) | JP2023538522A (enExample) |
| KR (1) | KR20230050379A (enExample) |
| CN (1) | CN116096365A (enExample) |
| AU (1) | AU2021320417A1 (enExample) |
| BR (1) | BR112023002085A2 (enExample) |
| CA (1) | CA3188213A1 (enExample) |
| IL (1) | IL300429A (enExample) |
| MX (1) | MX2023001481A (enExample) |
| WO (1) | WO2022032137A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA43734A (fr) | 2016-03-03 | 2018-11-28 | Regeneron Pharma | Procédés de traitement de patients atteints d'hyperlipidémie par administration d'un inhibiteur de pcsk9 en combinaison avec un inhibiteur d'angptl3 |
| US12559551B2 (en) | 2019-05-24 | 2026-02-24 | Regeneron Pharmaceuticals, Inc. | Stabilized formulations containing anti-ANGPTL3 antibodies |
| CA3246841A1 (en) * | 2022-04-04 | 2023-10-12 | Biomarin Pharmaceutical Inc. | TREATMENT FOR ENPP1 DEFICIENCY AND ABCC6 DEFICIENCY |
| WO2025185644A1 (zh) * | 2024-03-05 | 2025-09-12 | 江苏恒瑞医药股份有限公司 | 抗angptl3抗体治疗高血脂症的用途及方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6596541B2 (en) | 2000-10-31 | 2003-07-22 | Regeneron Pharmaceuticals, Inc. | Methods of modifying eukaryotic cells |
| WO2012168491A1 (en) | 2011-06-10 | 2012-12-13 | Novartis Ag | Pharmaceutical formulations of pcsk9 antagonists |
| AR087305A1 (es) | 2011-07-28 | 2014-03-12 | Regeneron Pharma | Formulaciones estabilizadas que contienen anticuerpos anti-pcsk9, metodo de preparacion y kit |
| EA039663B1 (ru) | 2012-05-03 | 2022-02-24 | Амген Инк. | Применение антитела против pcsk9 для снижения сывороточного холестерина лпнп и лечения связанных с холестерином расстройств |
| AU2015289617B2 (en) * | 2014-07-16 | 2021-04-15 | Regeneron Pharmaceuticals, Inc. | Methods for treating high cardiovascular risk patients with hypercholesterolemia |
| KR20230074283A (ko) * | 2014-07-16 | 2023-05-26 | 사노피 바이오테크놀로지 | 이형접합성 가족성 고콜레스테롤혈증(heFH) 환자의 치료방법 |
| MA43734A (fr) * | 2016-03-03 | 2018-11-28 | Regeneron Pharma | Procédés de traitement de patients atteints d'hyperlipidémie par administration d'un inhibiteur de pcsk9 en combinaison avec un inhibiteur d'angptl3 |
| PL3439689T3 (pl) * | 2016-04-08 | 2022-01-31 | Regeneron Pharmaceuticals, Inc. | Sposoby leczenia hiperlipidemii inhibitorem angptl8 i inhibitorem angptl3 |
| MD3448426T2 (ro) * | 2016-04-28 | 2025-09-30 | Regeneron Pharma | Metode de tratament al pacienților cu hipercolesterolemie familială |
-
2021
- 2021-08-06 MX MX2023001481A patent/MX2023001481A/es unknown
- 2021-08-06 IL IL300429A patent/IL300429A/en unknown
- 2021-08-06 KR KR1020237007956A patent/KR20230050379A/ko active Pending
- 2021-08-06 WO PCT/US2021/045008 patent/WO2022032137A1/en not_active Ceased
- 2021-08-06 EP EP21762903.9A patent/EP4192446A1/en not_active Withdrawn
- 2021-08-06 BR BR112023002085A patent/BR112023002085A2/pt unknown
- 2021-08-06 US US17/396,399 patent/US20220072127A1/en not_active Abandoned
- 2021-08-06 CN CN202180058786.0A patent/CN116096365A/zh not_active Withdrawn
- 2021-08-06 CA CA3188213A patent/CA3188213A1/en active Pending
- 2021-08-06 JP JP2023507911A patent/JP2023538522A/ja not_active Abandoned
- 2021-08-06 AU AU2021320417A patent/AU2021320417A1/en not_active Abandoned
-
2023
- 2023-12-12 US US18/537,578 patent/US20240197870A1/en not_active Abandoned